Envestnet, Inc. ENV is currently being aided by its recurring revenue-generation capacity and development in technology.ENV’s 2022 and 2023 revenues are anticipated to grow 4.7% and 4.3% each from the respective year-ago reported figures. Shares of ENV have rallied 24.6% in the past month compared with the 9.7% increase of the industry it belongs to.Image Source: Zacks Investment ResearchFactors That Augur WellEnvestnet’s business model ensures solid asset-based and subscription-based recurring revenue-generation capacity. ENV provides asset-based and subscription-based services on a business-to-business-to-consumer (B2B2C) basis to financial services clients. These clients offer solutions based on ENV’s platform to their end users.Envestnet continues focusing on technological upgrades to improve operational efficiency, increase market competitiveness, address regulatory demands and cater to client-driven requests for new capabilities. Currently, ENV’s technology platforms are based on a three-tier architecture combining a web-based user interface, an application tier housing the business logic for all the platforms’ functionality and an SQL Server database. Management believes that ENV’s technology-based designs allow significant scalability.A Key RiskEnvestnet's current ratio at the end of the September quarter was pegged at 0.64, lower than the current ratio of 0.77 reported at the end of the June quarter and the prior-year quarter’s current ratio of 2.04. A decreasing current ratio is undesirable as it indicates a company’s inefficiency in meeting its short-term debt obligations.Zacks Rank and Stocks to ConsiderEnvestnet currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Some better-ranked stocks in the broader Zacks Business Services sector are Booz Allen Hamilton Holding Corporation BAH, Paychex, Inc. PAYX and Cross Country Healthcare, Inc. CCRN.Booz Allen carries a Zacks Rank #2 (Buy) at present. BAH has a long-term earnings growth expectation of 7.5%.Booz Allen delivered a trailing four-quarter earnings surprise of 8.8%, on average.Paychex carries a Zacks Rank of 2 at present. PAYX has a long-term earnings growth expectation of 7.5%.Paychex delivered a trailing four-quarter earnings surprise of 8.6%, on average.Cross Country Healthcare sports a Zacks Rank #1, currently. CCRN has a long-term earnings growth expectation of 6%.CCRN delivered a trailing four-quarter earnings surprise of 10.1%, on average. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Paychex, Inc. (PAYX): Free Stock Analysis Report Envestnet, Inc (ENV): Free Stock Analysis Report Booz Allen Hamilton Holding Corporation (BAH): Free Stock Analysis Report Cross Country Healthcare, Inc. (CCRN): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research